2 18/03/2023 31/08/2024 2024-08-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2023-03-18 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 15081460 2023-03-18 2024-08-31 15081460 2024-08-31 15081460 2023-03-17 15081460 bus:RegisteredOffice 2023-03-18 2024-08-31 15081460 bus:LeadAgentIfApplicable 2023-03-18 2024-08-31 15081460 bus:Director1 2023-03-18 2024-08-31 15081460 bus:Director2 2023-03-18 2024-08-31 15081460 core:WithinOneYear 2024-08-31 15081460 bus:Micro-entities 2023-03-18 2024-08-31 15081460 bus:AuditExempt-NoAccountantsReport 2023-03-18 2024-08-31 15081460 bus:SmallCompaniesRegimeForAccounts 2023-03-18 2024-08-31 15081460 bus:PrivateLimitedCompanyLtd 2023-03-18 2024-08-31 15081460 bus:FullAccounts 2023-03-18 2024-08-31
Company registration number: 15081460
Dem Pharmaceuticals Limited
Unaudited filleted financial statements
for the period from 18 August 2023 to
31 August 2024
Dem Pharmaceuticals Limited
Contents
Directors and other information
Statement of financial position and notes to the financial statements
Dem Pharmaceuticals Limited
Directors and other information
Directors Y Demir (Appointed 18 August 2023)
T Hamit (Appointed 18 August 2023)
Company number 15081460
Registered office 64 Baker Street
London
W1U 7GB
Accountants Redford & Co Limited
Chartered Accountants
First Floor
64 Baker Street
London
W1U 7GB
Dem Pharmaceuticals Limited
Statement of financial position
31 August 2024
31/08/24
£
Current assets 11,967
Creditors: amounts falling due within one year ( 129,443)
_______
Net current liabilities ( 117,476)
_______
Total assets less current liabilities ( 117,476)
Accruals and deferred income ( 6,200)
_______
Net liabilities ( 123,676)
_______
Capital and reserves ( 123,676)
_______
Notes to the financial statements
Dem Pharmaceuticals Limited
Period ended 31 August 2024
1. Employee numbers
The average number of persons employed by the company during the period amounted to 2
For the period ending 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The member has not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 06 May 2025 , and are signed on behalf of the board by:
Y Demir
Director
Company registration number: 15081460
The company is a private company limited by shares, registered in England.